CRI Centro Regiomontano de Investigacion SC

Monterrey, Nuevo León 64710

0 studies enrolling now · 8 studies all time

What they study most

Alopecia Areata, Cardiovascular Disease, Depression, Depressive Disorder, Major, Migraine, Ulcerative Colitis

Studies at this site

• A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata — Completed
• Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis — Stopped early
• Vortioxetine to Prevent Return of Symptoms in Children With Depression — Stopped early
• Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age — Stopped early
• Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD) — Completed
• A Study of Lasmiditan (LY573144) Over Four Migraine Attacks — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early